Literature DB >> 11284041

Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: implications for genetic testing.

B Kuschel1, S A Gayther, D F Easton, B A Ponder, P D Pharoah.   

Abstract

We report an apparent BRCA1 homozygous knockout that, on further analysis, was found to be an artefact of the polymerase chain reaction. This finding has two important implications. First, it challenges results of a previous study that reported a homozygous knockout associated with the same BRCA1 mutation. Second, our findings suggest that mispriming caused by mismatched primers at the site of single-nucleotide polymorphisms, leading to preferential amplification of one allele, may represent a significant proportion of instances of mutation-detection insensitivity. This may have major implications for the sensitivity of all polymerase chain reaction-based mutation-detection methods in clinical genetic testing laboratories. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284041     DOI: 10.1002/gcc.1122

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

Authors:  Liu Cao; Wenmei Li; Sangsoo Kim; Steven G Brodie; Chu-Xia Deng
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

2.  Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.

Authors:  V Abkevich; A Zharkikh; A M Deffenbaugh; D Frank; Y Chen; D Shattuck; M H Skolnick; A Gutin; S V Tavtigian
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

Review 3.  The genetic epidemiology of breast cancer genes.

Authors:  Deborah Thompson; Douglas Easton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

4.  Offspring gender ratio and the rate of recurrent spontaneous miscarriages in jewish women at high risk for breast/ovarian cancer.

Authors:  Inbar Gal; Siegal Sadetzki; Ruth Gershoni-Baruch; Bernice Oberman; Howard Carp; Moshe Z Papa; Tal Diestelman-Menachem; Shlomit Eisenberg-Barzilai; Eitan Friedman
Journal:  Am J Hum Genet       Date:  2004-04-28       Impact factor: 11.025

5.  Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

Authors:  Susan M Domchek; Jiangbo Tang; Jill Stopfer; Dana R Lilli; Nancy Hamel; Marc Tischkowitz; Alvaro N A Monteiro; Troy E Messick; Jacquelyn Powers; Alexandria Yonker; Fergus J Couch; David E Goldgar; H Rosemarie Davidson; Katherine L Nathanson; William D Foulkes; Roger A Greenberg
Journal:  Cancer Discov       Date:  2012-12-26       Impact factor: 39.397

Review 6.  Methodologic quality and genotyping reproducibility in studies of tumor necrosis factor -308 G-->A single nucleotide polymorphism and bacterial sepsis: implications for studies of complex traits.

Authors:  Dixie L Peters; Robert C Barber; Elizabeth M Flood; Harold R Garner; Grant E O'Keefe
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

7.  A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.

Authors:  Heather L Hondow; Stephen B Fox; Gillian Mitchell; Rodney J Scott; Victoria Beshay; Stephen Q Wong; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2011-06-24       Impact factor: 4.430

8.  Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing.

Authors:  Anna P Sokolenko; Dmitry A Voskresenskiy; Aglaya G Iyevleva; Elena M Bit-Sava; Nadezhda I Gutkina; Maxim S Anisimenko; Nathalia Yu Sherina; Nathalia V Mitiushkina; Yulia M Ulibina; Olga S Yatsuk; Olga A Zaitseva; Evgeny N Suspitsin; Alexandr V Togo; Valery A Pospelov; Sergey P Kovalenko; Vladimir F Semiglazov; Evgeny N Imyanitov
Journal:  Hered Cancer Clin Pract       Date:  2009-01-26       Impact factor: 2.857

Review 9.  Preclinical mouse models for BRCA1-associated breast cancer.

Authors:  R M Drost; J Jonkers
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

10.  Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients.

Authors:  Eunjung Lee; Roberta McKean-Cowdin; Huiyan Ma; Zhengjia Chen; David Van Den Berg; Brian E Henderson; Leslie Bernstein; Giske Ursin
Journal:  Breast Cancer Res       Date:  2008-02-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.